The Centers for Disease Control and Prevention (CDC) views COVID-19 asan endemic virus. 1 Essentially it is circulating inperpetuityand we will witnessebbs and flows in prevalence.And certainly during ...

Findings from a study published in JAMA Network Open suggested that an association exists between asthma onset and memory and executive function difficulties in children. Seeking to determine this ...

A further understanding of the role SARS-CoV-2 plays in T2D incidence can add an important component to benefit and risk considerations to prevent COVID-19.

PIF Partners recently announced that 101-PGC-005 (‘005), a proprietary investigational therapeutic for the treatment of systemic juvenile idiopathic arthritis (sJIA) flares, has received Rare ...

As the authors emphasized, “Expansion of these services will be essential to meet the needs of patients experiencing food allergy-related anxiety." ...

Both monthly migraine days and headache days were reduced vs placebo in patients aged 6 to 17 years. Positive phase 3 data for fremanezumab (Ajovy;Teva Pharmaceutical Industries) has been reported for ...

From 2017-2018, antiviral treatment of hospitalized children with influenza ranged from 70%-86%. In the 2023-2024 season, it was less than 60%. A further ...

A new study highlights how depression may drive dysmenorrhea through shared genetic pathways, emphasizing the need for mental health screening and holistic care for women. There is an association ...

If approved, SL1009 has the potential to be the first approved medication for PDCD, and would be available as an oral solution. A New Drug Application SL1009, Sodium Dichloroacetate Oral Solution (DCA ...

The submission to treat PsO is for children aged 6 years and up while the jPsA submission is to treat children aged 5 years and older. A pair of supplemental Biologics License Applications (sBLAs) ...